Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXQ2WK
|
||||
Drug Name |
(S)-N-((R)-Benzyloxymethyl-cyano-methyl)-2-phenylamino-3-m-tolyl-propionamide
|
||||
Synonyms |
CHEMBL133508
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H27N3O2
|
||||
Canonical SMILES |
Cc1cccc(C[C@H](Nc2ccccc2)C(=O)N[C@@H](COCc3ccccc3)C#N)c1
|
||||
InChI |
InChI=1S/C26H27N3O2/c1-20-9-8-12-22(15-20)16-25(28-23-13-6-3-7-14-23)26(30)29-24(17-27)19-31-18-21-10-4-2-5-11-21/h2-15,24-25,28H,16,18-19H2,1H3,(H,29,30)/t24-,25+/m1/s1
|
||||
InChIKey |
SSNVUEXJJQDRMC-RPBOFIJWSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.